Gastrointestinal stromal tumors

Evolving role of the multidisciplinary team approach in management

Peter Reichardt, Carlo Morosi, Eva Wardelmann, Alessandro Gronchi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Gastrointestinal stromal tumors (GISTs) are rare tumors of the GI tract arising from mesenchymal cells. Treatment options include surgical resection and medical therapy with imatinib. A summary of National Comprehensive Cancer Network and European Society of Medical Oncology clinical practice guidelines relating to GIST management are presented here. A multidisciplinary team of physicians is essential to the successful treatment of GIST. Evidence supports multidisciplinary team management with a gastroenterologist, surgeon, medical oncologist, pathologist and radiologist. Consultations between them are recommended to ensure optimal care of patients with GIST. The role for individual core team workers is highlighted. The benefits of multidisciplinary disease management of patients include reducing recurrent disease, optimizing timing of surgery and organ preservation, prolonging survival for the patient and enhancing response to targeted therapies.

Original languageEnglish
Pages (from-to)1053-1068
Number of pages16
JournalExpert Review of Anticancer Therapy
Volume12
Issue number8
DOIs
Publication statusPublished - Aug 2012

Fingerprint

Gastrointestinal Stromal Tumors
Organ Preservation
Medical Oncology
Therapeutics
Disease Management
Practice Guidelines
Gastrointestinal Tract
Neoplasms
Patient Care
Referral and Consultation
Physicians
Survival

Keywords

  • gastrointestinal stromal tumor
  • medical oncologist
  • multidisciplinary team
  • pathologist
  • radiologist
  • surgeon

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Oncology

Cite this

Gastrointestinal stromal tumors : Evolving role of the multidisciplinary team approach in management. / Reichardt, Peter; Morosi, Carlo; Wardelmann, Eva; Gronchi, Alessandro.

In: Expert Review of Anticancer Therapy, Vol. 12, No. 8, 08.2012, p. 1053-1068.

Research output: Contribution to journalArticle

@article{5357818a76bf45378f38e80c5eeefbf4,
title = "Gastrointestinal stromal tumors: Evolving role of the multidisciplinary team approach in management",
abstract = "Gastrointestinal stromal tumors (GISTs) are rare tumors of the GI tract arising from mesenchymal cells. Treatment options include surgical resection and medical therapy with imatinib. A summary of National Comprehensive Cancer Network and European Society of Medical Oncology clinical practice guidelines relating to GIST management are presented here. A multidisciplinary team of physicians is essential to the successful treatment of GIST. Evidence supports multidisciplinary team management with a gastroenterologist, surgeon, medical oncologist, pathologist and radiologist. Consultations between them are recommended to ensure optimal care of patients with GIST. The role for individual core team workers is highlighted. The benefits of multidisciplinary disease management of patients include reducing recurrent disease, optimizing timing of surgery and organ preservation, prolonging survival for the patient and enhancing response to targeted therapies.",
keywords = "gastrointestinal stromal tumor, medical oncologist, multidisciplinary team, pathologist, radiologist, surgeon",
author = "Peter Reichardt and Carlo Morosi and Eva Wardelmann and Alessandro Gronchi",
year = "2012",
month = "8",
doi = "10.1586/era.12.48",
language = "English",
volume = "12",
pages = "1053--1068",
journal = "Expert Review of Molecular Diagnostics",
issn = "1473-7159",
publisher = "Expert Reviews Ltd.",
number = "8",

}

TY - JOUR

T1 - Gastrointestinal stromal tumors

T2 - Evolving role of the multidisciplinary team approach in management

AU - Reichardt, Peter

AU - Morosi, Carlo

AU - Wardelmann, Eva

AU - Gronchi, Alessandro

PY - 2012/8

Y1 - 2012/8

N2 - Gastrointestinal stromal tumors (GISTs) are rare tumors of the GI tract arising from mesenchymal cells. Treatment options include surgical resection and medical therapy with imatinib. A summary of National Comprehensive Cancer Network and European Society of Medical Oncology clinical practice guidelines relating to GIST management are presented here. A multidisciplinary team of physicians is essential to the successful treatment of GIST. Evidence supports multidisciplinary team management with a gastroenterologist, surgeon, medical oncologist, pathologist and radiologist. Consultations between them are recommended to ensure optimal care of patients with GIST. The role for individual core team workers is highlighted. The benefits of multidisciplinary disease management of patients include reducing recurrent disease, optimizing timing of surgery and organ preservation, prolonging survival for the patient and enhancing response to targeted therapies.

AB - Gastrointestinal stromal tumors (GISTs) are rare tumors of the GI tract arising from mesenchymal cells. Treatment options include surgical resection and medical therapy with imatinib. A summary of National Comprehensive Cancer Network and European Society of Medical Oncology clinical practice guidelines relating to GIST management are presented here. A multidisciplinary team of physicians is essential to the successful treatment of GIST. Evidence supports multidisciplinary team management with a gastroenterologist, surgeon, medical oncologist, pathologist and radiologist. Consultations between them are recommended to ensure optimal care of patients with GIST. The role for individual core team workers is highlighted. The benefits of multidisciplinary disease management of patients include reducing recurrent disease, optimizing timing of surgery and organ preservation, prolonging survival for the patient and enhancing response to targeted therapies.

KW - gastrointestinal stromal tumor

KW - medical oncologist

KW - multidisciplinary team

KW - pathologist

KW - radiologist

KW - surgeon

UR - http://www.scopus.com/inward/record.url?scp=84867054984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867054984&partnerID=8YFLogxK

U2 - 10.1586/era.12.48

DO - 10.1586/era.12.48

M3 - Article

VL - 12

SP - 1053

EP - 1068

JO - Expert Review of Molecular Diagnostics

JF - Expert Review of Molecular Diagnostics

SN - 1473-7159

IS - 8

ER -